ReviewFrontiers in microbiology2015
Novel Routes for Improving Biocontrol Activity of Bacillus Based Bioinoculants.
Review in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed.
- Article
- Review
- Integrated multi-omics and phenotypic validations reveal biocontrol mechanisms ofFrontiers in microbiology · 2026Article
- Isolation and Genome-Based Characterization ofMicroorganisms · 2025Article
- Pharmacological assessment of the extract and a novel compound of Bacillus velezensis DM derived from the rhizosphere of Datura metel L. with microbial molecular screening.BMC complementary medicine and therapies · 2025Article
- Exploring the Perilous Nature of Phytophthora: Insights into Its Biology, Host Range, Detection, and Integrated Management Strategies in the Fields of Spices and Plantation Crops.The plant pathology journal · 2025Review
- Prospecting the Functional Potential of Bacillus altitudinis 1.4 Isolated from Sediment in Association with Bradyrhizobium japonicum.Current microbiology · 2025Article
- Paenibacillus as a Biocontrol Agent for Fungal Phytopathogens: Is P. polymyxa the Only One Worth Attention?Microbial ecology · 2024Review
- Genome Sequencing and Characterization ofMicroorganisms · 2024Article
- Antagonistic interactions between maize seeds microbiome species and the late wilt disease agent,Frontiers in fungal biology · 2024Article
- Plant-Associated Representatives of theMicroorganisms · 2023Article
- Surfactin and Spo0A-Dependent Antagonism byPlants (Basel, Switzerland) · 2023Article
- Characterization and evaluation ofFrontiers in microbiology · 2023Article
- Thermo-neutrophilic cellulases and chitinases characterized from a novel putative antifungal biocontrol agent: Bacillus subtilis TD11.PloS one · 2023Article
- Characterization ofMicroorganisms · 2022Article
- Article
- Soil Bacterial Community May Offer Solutions for Ginger Cultivation.Microbiology spectrum · 2022Article
- Salt TolerantPlants (Basel, Switzerland) · 2022Article
- Bacteria as Biological Control Agents of Plant Diseases.Microorganisms · 2022Review
- Bioactivities evaluation of an endophytic bacterial strain Bacillus velezensis JRX-YG39 inhabiting wild grape.BMC microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biocontrol (BC) formulations prepared from plant-growth-promoting bacteria are increasingly applied in sustainable agriculture. Especially inoculants prepared from endospore-forming Bacillus strains have been proven as efficient and environmental-friendly alternative to chemical pesticides due to their long shelf life, which is comparable with that of agrochemicals. However, these formulations of the first generation are sometimes hampered in their action and do not fulfill in each case the expectations of the appliers. In this review we use the well-known plant-associated Bacillus amyloliquefaciens type strain FZB42 as example for the successful application of different techniques offered today by comparative, evolutionary and functional genomics, site-directed mutagenesis and strain construction including marker removal, for paving the way for preparing a novel generation of BC agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.